Nuvalent Financial Statements From 2010 to 2024
| NUVL Stock | USD 101.30 0.75 0.73% |
Market Capitalization 7.1 B | Earnings Share (2.79) |
Check Nuvalent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvalent's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nuvalent financial statements analysis is a perfect complement when working with Nuvalent Valuation or Volatility modules.
Nuvalent |
Nuvalent Company Return On Equity Analysis
Nuvalent's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nuvalent Return On Equity | -0.33 |
Most of Nuvalent's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nuvalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nuvalent has a Return On Equity of -0.3281. This is 98.63% lower than that of the Biotechnology sector and 99.1% lower than that of the Health Care industry. The return on equity for all United States stocks is 5.84% higher than that of the company.
Nuvalent Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nuvalent's current stock value. Our valuation model uses many indicators to compare Nuvalent value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nuvalent competition to find correlations between indicators driving Nuvalent's intrinsic value. More Info.Nuvalent is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Nuvalent by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Nuvalent Financial Statements
Nuvalent investors utilize fundamental indicators, such as revenue or net income, to predict how Nuvalent Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Nuvalent Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Nuvalent Stock
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:Check out the analysis of Nuvalent Correlation against competitors. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.23) | Return On Equity (0.33) |
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.